WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production (Q39088795)

9 September 2017

title

WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production (English)

1 reference

9 September 2017

3

1 reference

Anne-Marie Lefrançois-Martinez

9 September 2017

17

Jérôme Bertherat

0 references

16

Anne-Marie Lefrançois-Martinez

0 references

Isabelle Sahut-Barnola

13

Isabelle Sahut-Barnola

0 references

Marie Batisse-Lignier

14

Marie Batisse-Lignier

0 references

Sheerazed Boulkroun

Sheerazed Boulkroun

4

0 references

Guillaume Assié

Guillaume Assié

15

0 references

Maria-Christina Zennaro

Maria-Christina Zennaro

8

0 references

Laurence Amar

Laurence Amar

6

0 references

author name string

Annabel Berthon

1

1 reference

9 September 2017

Coralie Drelon

2

1 reference

9 September 2017

Frédérique Tissier

5

1 reference

9 September 2017

Benoît Samson-Couterie

7

1 reference

9 September 2017

Pierre-François Plouin

9

1 reference

9 September 2017

Seham Skah

10

1 reference

9 September 2017

Michelina Plateroti

11

1 reference

9 September 2017

Hervé Lefèbvre

12

1 reference

9 September 2017

Antoine Martinez

18

1 reference

9 September 2017

Pierre Val

19

1 reference

9 September 2017

publication date

1 October 2013

1 reference

9 September 2017

published in

Human Molecular Genetics

1 reference

9 September 2017

volume

23

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

889-905

1 reference

Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Changes in the perceived epidemiology of primary hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Efficacy and tolerance of spironolactone in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

TASK channel deletion in mice causes primary hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Wnt/β-catenin signalling in adrenal physiology and tumour development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Brachy-syndactyly caused by loss of Sfrp2 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Disabled-2 is expressed in adrenal zona glomerulosa and is involved in aldosterone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Apc tumor suppressor gene is the "zonation-keeper" of mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

MEF2A regulates the Gtl2-Dio3 microRNA mega-cluster to modulate WNT signaling in skeletal muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Adenovirus-delivered DKK3/WNT4 and steroidogenesis in primary cultures of adrenocortical cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Convergence of 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A and glycogen synthase kinase-3beta/beta-catenin signaling in corpus luteum progesterone synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Follicle-stimulating hormone/cAMP regulation of aromatase gene expression requires beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

WNT signaling in ovarian follicle biology and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

WNT4 is required for normal ovarian follicle development and female fertility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Conditional deletion of beta-catenin mediated by Amhr2cre in mice causes female infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Inhibition of β-catenin signaling by nongenomic action of orphan nuclear receptor Nur77

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Cross-talk between NR4A orphan nuclear receptors and β-catenin signaling pathway in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Mitogenic Effect of Orphan Receptor TR3 and Its Regulation by MEKK1 in Lung Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

The flavonoid quercetin in disease prevention and therapy: facts and fancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Targeting Wnt signaling: can we safely eradicate cancer stem cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Protocol for the fast chromatin immunoprecipitation (ChIP) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

Aldosterone-Producing Adenoma Formation in the Adrenal Cortex Involves Expression of Stem/Progenitor Cell Markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT484

21 January 2018

Identifiers

DOI

10.1093/HMG/DDT484

1 reference

9 September 2017

1 reference